Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126792982 | 12679298 | 2 | F | 20160823 | 20160824 | 20160830 | EXP | GB-MHRA-EYC 00143694 | GB-DRREDDYS-GER/UKI/16/0082543 | DR REDDYS | 0.00 | M | Y | 0.00000 | 20160830 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126792982 | 12679298 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | Y | U | UNKNOWN | 76692 | 10 | MG | QD | |||||
126792982 | 12679298 | 2 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | Y | U | 0 | 20 | MG | QD | ||||||
126792982 | 12679298 | 3 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | Y | U | 0 | 25 | MG | TABLET | QD | |||||
126792982 | 12679298 | 4 | SS | PERINDOPRIL | PERINDOPRIL | 1 | Oral | Y | U | 0 | 8 | MG | QD | ||||||
126792982 | 12679298 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
126792982 | 12679298 | 6 | C | Atorvastatin | ATORVASTATIN | 1 | 0 | ||||||||||||
126792982 | 12679298 | 7 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
126792982 | 12679298 | 8 | C | CODEINE | CODEINE | 1 | 0 | ||||||||||||
126792982 | 12679298 | 9 | C | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | 0 | ||||||||||||
126792982 | 12679298 | 10 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
126792982 | 12679298 | 11 | C | LOPERAMIDE | LOPERAMIDE | 1 | 0 | ||||||||||||
126792982 | 12679298 | 12 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 | ||||||||||||
126792982 | 12679298 | 13 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
126792982 | 12679298 | 14 | C | QUININE | QUININE | 1 | 0 | ||||||||||||
126792982 | 12679298 | 15 | C | SALBUTAMOL | ALBUTEROL | 1 | 0 | ||||||||||||
126792982 | 12679298 | 16 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
126792982 | 12679298 | 17 | C | SULFASALAZINE. | SULFASALAZINE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126792982 | 12679298 | 1 | Product used for unknown indication |
126792982 | 12679298 | 2 | Product used for unknown indication |
126792982 | 12679298 | 3 | Product used for unknown indication |
126792982 | 12679298 | 4 | Product used for unknown indication |
126792982 | 12679298 | 5 | Product used for unknown indication |
126792982 | 12679298 | 6 | Product used for unknown indication |
126792982 | 12679298 | 7 | Product used for unknown indication |
126792982 | 12679298 | 8 | Product used for unknown indication |
126792982 | 12679298 | 9 | Product used for unknown indication |
126792982 | 12679298 | 10 | Product used for unknown indication |
126792982 | 12679298 | 11 | Product used for unknown indication |
126792982 | 12679298 | 12 | Product used for unknown indication |
126792982 | 12679298 | 13 | Product used for unknown indication |
126792982 | 12679298 | 14 | Product used for unknown indication |
126792982 | 12679298 | 15 | Product used for unknown indication |
126792982 | 12679298 | 16 | Product used for unknown indication |
126792982 | 12679298 | 17 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126792982 | 12679298 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126792982 | 12679298 | Fall | |
126792982 | 12679298 | Orthostatic hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |